Gentian Violet Treatment for Hidradenitis Suppurativa
Withdrawn Phase 2 NCT04388163
Study Description
A Study to Evaluate the Effectiveness of Gentian Violet in Treating Hidradenitis Suppurativa
Study Details
- Registry ID:
- NCT04388163
- Conditions:
- Hidradenitis Suppurativa
- Phase:
- Phase 2
- Start Date:
- Age Range:
- 18–64 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.